However, body weight remained significantly lower in these groups throughout the 21-day study, suggesting that cagrilintides weight-lowering action extends beyond acute appetite suppression
Kulkarni K, Kelderman J, Coleman H, Aguilar M-I, Parkington H, Del Borgo M
Therapeutic peptides significantly reduce production of these inflammatory messengers while promoting anti-inflammatory signals
Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use